Related references
Note: Only part of the references are listed.Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team
Francesco Pelliccia et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Fixed, high-volume alcohol dose for septal ablation: High risk with no benefit
Carey Kimmelstiel et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2020)
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy
Michele Ciabatti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Steve R. Ommen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort
Anita Nguyen et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2019)
Choice of Septal Reduction Therapies and Alcohol Septal Ablation
Michael A. Fifer
CARDIOLOGY CLINICS (2019)
Historical Perspectives in the Evolution of Hypertrophic Cardiomyopathy
Julio A. Panza et al.
CARDIOLOGY CLINICS (2019)
Performance Volume Thresholds for Alcohol Septal Ablation in Treating Hypertrophic Cardiomyopathy: Guidelines, Competency Statements, and Now Data
Srihari S. Naidu
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Effect of Institutional Experience on Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
Josef Veselka et al.
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy
Angelika Batzner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy
Michael A. Fifer
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy A Word of Balance
Paul Sorajja
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Hypertrophic obstructive cardiomyopathy
Josef Veselka et al.
LANCET (2017)
Effect of Alcohol Dosage on Long-Term Outcomes After Alcohol Septal Ablation in Patients With Hypertrophic Cardiomyopathy
Max Liebregts et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2016)
Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry
Josef Veselka et al.
EUROPEAN HEART JOURNAL (2016)
Obstruction after alcohol septal ablation is associated with cardiovascular mortality events
Josef Veselka et al.
HEART (2016)
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Survival After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Paul Sorajja et al.
CIRCULATION (2012)
Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years
Josef Veselka et al.
CANADIAN JOURNAL OF CARDIOLOGY (2011)
Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy A Multicenter North American Registry
Sherif F. Nagueh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Correlation Between Serum Cardiac Markers and Myocardial Infarct Size Quantified by Myocardial Perfusion Imaging in Patients With Hypertrophic Cardiomyopathy After Alcohol Septal Ablation
Fadi G. Hage et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy -: A single-center, prospective, and randomized study
Josef Veselka et al.
CIRCULATION JOURNAL (2006)
A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy - The Baylor experience (1996-2002)
VL Fernandes et al.
CLINICAL CARDIOLOGY (2005)
Catheter-based therapy for hypertrophic obstructive cardiomyopathy - First in-hospital outcome analysis of the German TASH Registry
H Kuhn et al.
ZEITSCHRIFT FUR KARDIOLOGIE (2004)
Share Paper
